DANYIELLE JERNUKIAN: Open Payments
NPI 1861097263 · SOUTHFIELD, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,600 in 40 payments from 18 companies in 2025. Trend: 2023 $1,874 · 2024 $1,771 · 2025 $1,600
Food & beverage: $1,600
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $275 |
| Alexion Pharmaceuticals, Inc. | 5 | $177 |
| ARGENX US, INC. | 6 | $170 |
| Lilly USA, LLC | 5 | $153 |
| TG Therapeutics, Inc. | 1 | $150 |
| Regeneron Healthcare Solutions, Inc. | 2 | $122 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $122 |
| Pharmacosmos Therapeutics Inc. | 1 | $107 |
| Amgen Inc. | 1 | $82 |
| ABBVIE INC. | 2 | $45 |
Products named: TREMFYA, BRIUMVI, ULTOMIRIS, LIBTAYO, ENTYVIO, VYVGART HYTRULO, MONOFERRIC, KISUNLA.
Industry payments across MI — which companies pay providers there.
